CompletedNCT03006965

Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®

Studying Hemophilia

Last synced from ClinicalTrials.gov May 10, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Spanish Society of Thrombosis and Haemostasis
Principal Investigator: M Teresa Álvarez Román, MD,PhD
Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid
Intervention: octocog alfa(drug)
Enrollment: 50 enrolled
Eligibility: 1-65 years · MALE
Timeline: 2016 – 2022

Study locations (14)

Complexo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain
Hospital Universitario Son Espases, Palma, Balearic Islands, Spain
Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain
Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
Hospital Virgen del Camino, Pamplona, Navarre, Spain
Hospital Xeral de Vigo, Vigo, Pontevedra, Spain
Hospital Universitario Central de Asturias, Oviedo, Principality of Asturias, Spain
Hospital Universitario Cruces, Barakaldo, Vizcaya, Spain
Hospital Vall D'Hebron, Barcelona, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Regional Universitario de Málaga, Málaga, Spain
Hospital Materno-infantil de Málaga, Málaga, Spain
Hospital Universitario Virgen del Rocío, Seville, Spain
Hospital Universitari i Politècnic La Fe, Valencia, Spain

Collaborators

Takeda · Instituto de Investigación Hospital Universitario La Paz

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03006965 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials